(Q42988882)

English

Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load.

scientific article published on January 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Hiromitsu Kumada

11

object named as

Hiromitsu Kumada

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Fumitaka Suzuki

5

object named as

Fumitaka Suzuki

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

7

object named as

Kenji Ikeda

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Masahiro Kobayashi

10

object named as

Masahiro Kobayashi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Yoshiyuki Suzuki

4

object named as

Yoshiyuki Suzuki

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

8

object named as

Norio Akuta

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

2

object named as

Yasuji Arase

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

6

object named as

Satoshi Saitoh

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

3

object named as

Takashi Someya

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Akihito Tsubota

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

75

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

27-34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Estimation of early hepatitis C viral clearance in patients receiving daily interferon and ribavirin therapy using a mathematical model

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Viral kinetics and treatment response in patients with hepatitis C during induction and standard interferon therapy in combination with ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Early detection of nonresponse to interferon plus ribavirin combination treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Combination of interferon induction therapy and ribavirin in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Standardization of hepatitis C virus RNA quantification

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Comparison of 3 quantitative HCV RNA assays--accuracy of baseline viral load to predict treatment outcome in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

National institutes of health consensus development conference statement: Management of hepatitis C: 2002 — June 10–12, 2002

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20232

21 January 2018

Identifiers

10.1002/JMV.20232

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

release_6khzjptrf5h6pcygnlzyqajso4

1 reference

https://api.fatcat.wiki/v0/release/6khzjptrf5h6pcygnlzyqajso4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15543591%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42988882&oldid=1842256760"